Join to View Full Profile
13220 USF Laurel Dr, Tampa, FL 33612Tampa, FL 33612
Phone+1 813-974-9413
Fax+1 813-974-7138
Dr. Vu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York-Presbyterian HospitalPost-Doctoral Fellowship, 1994 - 1996- New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuromuscular Medicine (Neurology), 1993 - 1994
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1990 - 1993
Penn State Milton S Hershey Medical CenterInternship, Internal Medicine, 1989 - 1990
Pennsylvania State University College of MedicineClass of 1989
Certifications & Licensure
FL State Medical License 2010 - 2026
PA State Medical License 1989 - 2010
NJ State Medical License 1994 - 2003
NY State Medical License 1992 - 2002
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
American Board of Electrodiagnostic MedicineFellow
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Clinical Trials
- Phase 3 Study of Dexpramipexole in ALS Start of enrollment: 2011 Mar 01
- The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis Start of enrollment: 2011 Jan 01
- Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Join now to see all
Publications & Presentations
PubMed
- Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study.Vera Bril, Artur Drużdż, Julian Grosskreutz, Ali A Habib, Henry J Kaminski
Journal of Neurology. 2025-03-19 - 1 citationsRozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions.Vera Bril, Artur Drużdż, Julian Grosskreutz, Ali A Habib, Renato Mantegazza
Journal of Neuromuscular Diseases. 2025-03-04 - 1 citationsLong-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension.Ali A Habib, Artur Drużdż, Julian Grosskreutz, Renato Mantegazza, Sabrina Sacconi
Journal of Neuromuscular Diseases. 2025-03-04
Journal Articles
- Terminal Complement Inhibitory Ravulizumab in Generalized Myasthenia Gravis.Tuan Vu, M.D.,1 Andreas Meisel, M.D.,2 Renato Mantegazza, M.D.,3 Djillali Annane, M.D.,4 Masahisa Katsuno, M.D.,5 Rasha Aguzzi, M.S.,6 Ahmed Enayetallah, M.D., Ph.D.,6..., NEJM Evidence 1 (5). April 2022., 4/2022
Press Mentions
Cartesian Therapeutics Expands Clinical Advisory Board with Five Internationally Recognized Experts in AutoimmunityMarch 28th, 2023
Grant Support
- Mitochondrial DNA Depletion In Hepatoneural SyndromesNational Institute Of Neurological Disorders And Stroke2001
- Mitochondrial DNA Depletion In Human DiseaseNational Institute Of Neurological Disorders And Stroke1996–2000
Professional Memberships
- Member
Other Languages
- Vietnamese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
